US state jury votes in favour of 3M in implant case:
This article was originally published in Clinica
Executive Summary
A jury in Albuquerque, New Mexico, has ruled for 3M in five out of six issues connected with a breast implant case. Last October, a jury in Memphis, Tennessee, ruled in favour of the company in a similar case (see Clinica No 729, p 3).
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.